Table 3.
Additional explained variance by a genetic risk score based on FGF-signaling pathway 14.
| Phenotype | Additional explained variance by signaling pathway genetic risk score (%) |
|---|---|
| Adult systolic blood pressure (Rotterdam Study III) | 0.1 |
| Adult diastolic blood pressure (Rotterdam Study III) | 0.0 |
| Child systolic blood pressure (Generation R) | 0.1 |
| Child diastolic blood pressure (Generation R) | 0.1 |
| Hypertension – SBP scores (Rotterdam Study III) | 0.3 * |
| Hypertension – DBP scores (Rotterdam Study III) | 0.1 |
*
P value < 0.05